adjust ep beat
announc adj ep estim consensu
organ growth slightli ahead estim ri margin higher
model improv organ growth rate vs posit given concern
revenu breakag jlt deal ep beat also seen favor
jlt deal make quarterli forecast difficult still face
headwind jlt acquisit non-compet depart
produc land new home still follow modestli disappoint
third quarter result posit stock view
risk srvc organ growth margin solid
ri organ growth estim due growth guy
carpent turnaround shortfal exclud true-up form multi-year
deal growth mid-singl digit still better expect marsh organ
growth slightli better-than-expect asia pacif lead way
us/canada grew line growth rate margin in-lin
consult earn close estim
adjust consult earn line consult organ revenu growth
slow last quarter line forecast mercer singl biggest
practic wealth report growth nil line improv
recent declin oliv wyman growth continu respect although
manag warn pull-back margin good segment
improv basi point year ago quarter beat estim
littl chang estim rais
rais estim per share due beat
quarter off-set drag fx slight increas assum margin
brought forecast nickel shift price target
earn assum multipl support expect
doubl digit ep growth good cash gener total return potenti
remain neutral share
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
total benefit claim
total invest
oper return averag asset
long term debt cap ratio ex fa
amtz dac pre-tax profit bef amtz dac
marsh mclennan one world largest
insur broker subsidiari
affili provid rang insur
servic reinsur program manag
consult servic three main busi
insur servic insur reinsur
done credibl job improv
brokerag margin manag
difficult environ believ
consult busi challeng improv
margin near-term valuat
becom less attract earn growth
increasingli determin revenu growth
invest growth opportun
invest take time pay
comp benefit
compani document bofa merril lynch global research
estim
tabl marsh mclennan earn model million
comp benefit
compani document bofa merril lynch global research
price object base estim multipl support
expect consist low doubl digit ep growth time risk price
object declin property-casualty premium rate pressur
revenu margin oper disrupt caus restructur effort
turnov senior manag produc level lower fiduciari invest
incom due drop short-term interest rate chang health care regul
impact benefits-consult busi neg impact moral anoth
restructur effort recessionari environ hurt demand
insur broke consult servic
jay cohen herebi certifi view express research report accur
reflect person view subject secur issuer also certifi
part compens directli indirectli relat specif
recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
